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Abstract
AIM: We aimed to compare the expression of MMP-9 in TB spondylitis using serum levels in the blood of patients 
suffering from TB spondylitis and compared to the control group.
METHODS: Fourteen subjects were divided into two groups, with seven subjects of spondylitis tuberculous (TB) and 
seven subjects of degenerative spine disease (DSD) in the period from December 2017 to November 2018, who 
were included in the inclusion criteria included in this study and blood sampling was taken for examination of serum 
matrix metalloproteinase (MMP)-9 levels. 
RESULTS: There were significant differences in serum MMP-9 levels between spondylitis TB (ST) and DSDs with 
a significance value of 0.002 (p < 0.05) with low serum MMP-9 levels in the ST study group 1857.14 ± 377.96 and 
mean in the control group 857.14 ± 243.97. There were significant differences in serum MMP-9 levels between ST 
and DSDs with a significance value of 0.002 (p < 0.05) with low serum MMP-9 levels in the ST study group 1857.14 
± 377.96 and mean in the control group 857.14 ± 243.97. 
CONCLUSION: Patients suffering from ST have higher serum MMP-9 levels than patients with DSD, although 
MMP-9 is not a specific marker examination for ST, the results of this study can be suggestive into that can help to 
evaluate enzyme activity in patients with ST disease.
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Introduction
Tuberculous (TB) is one of the long-known 
diseases and is still the leading cause of death in the world. 
The prevalence of TB in Indonesia and other developing 
countries is quite high. In 2006, new cases in Indonesia 
amounted to more than 600,000, and most of them were 
suffered by people in productive age (15–55 years).
About 20% of infections with pulmonary TB will 
spread out of the lungs (extrapulmonary TB). Eleven 
percent of extrapulmonary TB is osteoarticular TB, and 
nearly half of patients suffer from spinal TB infection. 
Half have lesions in the spine with neurological deficits 
of 10–45% of sufferers. 
Spondylitis TB (ST) is an infection of the spine 
caused by Mycobacterium tuberculosis [1], [2], [3] ST 
results in damage to the body in the form of a defect that 
causes spinal instability and disruption of surrounding 
structures [1], [3]. The occurrence of infection in ST can 
originate from primary infection [2], [4], bacteria directly 
infect the corpus, or secondary infections [4], namely, 
bacteria spread hematogenously or lymphogenously from 
the location of the primary disease to the spinal cord [2]. 
Infections that occur in ST are generally secondary infections 
of the lungs, but some cases are primary infections. 
Pro-inflammatory and anti-inflammatory cytokines play 
an important role in the development and control of M. 
tuberculosis infection [5]. It has been demonstrated that 
cytokine profiles will differ in each degree of disease [1], [5]. 
Several cytokines have been known to be biomarkers of 
disease activity in TB infections. Matrix metalloproteinase 
(MMP) is a zinc-dependent protease, which plays a role in 
the process of degradation of the extracellular matrix and 
modulates the inflammatory response by facilitating and 
inhibiting different cytokines [6], [7], [8].
In determining the form of treatment for ST, it 
is generally divided into two groups of patients, namely, 
groups of patients accompanied by complications in 
the way of neurological disorders and groups that are 
not accompanied by neurological disorders. In patients 
without neurological complications, medical treatment is 
the primary choice in treatment, and surgical treatment 
is only needed in some special cases. However, 
in patients who are accompanied by neurological 
complications, the combination of medical treatment 
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and surgical management is the most appropriate 
treatment.
MMP is a zinc-dependent proteinase that has 
an important role in the degradation and rotation of the 
extracellular matrix [3]. Since it was first reported, 24 
members of MMP have been identified with specificity 
and function of overlapping substrates. Following each 
substrate and function specification, MMP is divided into 
six classes: Stromelysins, collagenases, matrilysins, 
gelatinases, membrane-type MMPs, and others.
Two gelatinases, MMP-2, and MMP-9, can reduce 
original type IV collagen and denaturation of type I collagen 
(gelatin). Both circulation and resident inflammatory 
cells can synthesize MMP-9. Experimental studies have 
provided evidence that MMP-9 levels were significantly 
higher in bronchoalveolar fluid patients with cavitary active 
TB and lung extracts of mice infected with M. tuberculous, 
compared to the control group. An increased significance 
of MMP-9 was also observed in TB cerebrospinal fluid 
(CSF) meningitis patients and also compared with people 
suffering from viral meningitis, where usually these 
enzymes are generally not found in CSF.
Many previous studies have shown that 
M. tuberculous can stimulate MMP-9 expression in 
the lungs of infected organisms, but no studies have 
examined how the expression of MMP-9 in TB spondylitis 
when compared to the control group. Therefore, 
researchers are interested in trying to evaluate and 
compare the expression of MMP-9 in TB spondylitis 
using serum levels in the blood of patients suffering 
from TB spondylitis and compared to the control group; 
in this case, the control group in this study was patients 
with degenerative diseases of the spine.
Methods
This cross-sectional study was conducted at 
the Faculty of Medicine, Universitas Sumatra Utara/
Haji Adam Malik Hospital, North Sumatra, Indonesia, 
for 11 months from December 2017 to November 2018 
by taking patient data and examining serum values of 
MMP-9, 14 subjects met the inclusion criteria.
Patients who met the inclusion criteria recorded 
age, sex, and blood tests to determine serum MMP-9 levels.
The study sample was divided consecutively 
with equal numbers into two groups, namely, ST and 
degenerative spine disease (DSD). Patients were obtained 
from outpatient or inpatient care diagnosed with ST and 
DSD. Patients who were included in the inclusion criteria 
were taken for blood sampling to examine levels of MMP-9.
The MMP-9 examination in this study used 
MMP-9 ELISA Kit from Fine Test with the catalog number 
ERB0080, size 48T/96T, and reactivity to humans. The 
scale value used is 3.125–200 ng/ml with sensitivity: 
<1.875 ng/ml. The application of the dosage is a 
quantitative detection of MMP-9 in serum, plasma, tissue 
homogenates, and other biological fluids. D i f fe rences 
in serum MMP-9 values in ST with the degenerative 
disease in the spine were analyzed using the Mann–
Whitney U-test because the data obtained were 
abnormally distributed. All statistical calculations are 
carried out using a computer-based statistical program. 
The study was approved by the Health Research Ethics 
Committee of the Medical Faculty of the University of 
North Sumatra/Haji Adam Malik Hospital, and informed 
consent was obtained from all subjects.
Results
Before discussing the results of the study, 
because this study had no references, it was conducted 
with a small-scale preliminary study using ten balanced 
numbers of research subjects (five subjects with ST 
and five subjects with DSD) with women as many as 
6 people (60%) and men as many as 4 people (40%). 
With a mean and standard deviation of 41.6 ± 18.8 
years. While the mean of subjects with ST 1800 ± 447.2 
and mean DSD 800 ± 273.8 (Table 1).
Table 1: Preliminary study distribution
Variable Disease
ST DSD
Gender M/F ¼ 3/2
MMP-9 (nm/ml) 1800 ± 447.2 800 ± 273.8
Mean age 41.6 ± 18.8
ST: Spondylitis tuberculous, DSD: Degenerative spine disease, n: Subject.
A total of 14 subjects were studied until the 
final analysis. Data retrieval and examination of serum 
MMP-9 values in ST and DSD were carried out in stages 
with the initial phase of selecting samples of subjects 
included in the inclusion criteria: seven subjects with 
diagnosed ST, 7 subjects with diagnoses of DSD; 8 
women (57.1%), and 6 men (42.9%); 13 years old are 
the youngest research subjects and 73 years old oldest 
subjects with mean and standard deviations amounting 
to 44.79 ± 16.98 years. From the results of the analysis, 
it was found that the mean and standard deviation of 
serum ST MMP-9 values were 1857.14 ± 377.96, while 
the mean and standard deviation of serum DSD levels 
of MMP-9 were 857.14 ± 243.97 (Table 2).
Table 2: Study subject distribution
Variable Disease
ST MMP-9 (nm/ml) DSD MMP-9 (nm/ml)
Patient
1 2000 1000
2 1000 1000
3 2000 500
4 2000 500
5 2000 1000
6 2000 1000
7 2000 1000
Mean MMP-9 (nm/ml) 1857.14 857.14
SD ± 377.96 ± 243.97
p-value 0.002
Youngest age 13 year old 43 year old
Oldest age 62 year old 73 year old
Tuberculous drug consumption 9.14 ± 5.29 weeks 0
ST: Spondylitis tuberculous, DSD: Degenerative spine disease, n: Subject.
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From the results of the statistical analysis of 
the comparison of serum MMP-9 values in ST with 
DSD, the results were significant that the serum MMP-9 
values were higher, and this was indicated by p = 0.002 
(p <0.05).
Discussion
Pott’s disease is the most common spinal 
granulomatous bacterial infection and is the most 
frequent bone TB [5]. The occurrence of infection in 
spondylitis tuberculous can originate from primary 
infection [2], [4], that is, bacteria directly infect the 
corpus, or secondary infections [6], namely, bacteria 
spread hematogenously or lymphogens from the 
location of the primary infection to the spinal cord [2]. 
Infections that occur in ST are generally secondary 
infections of the lungs, but some cases are primary 
infections. Pro-inflammatory and anti-inflammatory 
cytokines play an important role in the development 
and control of M. tuberculous infection [5].  Several 
cytokines have been known to be biomarkers of 
disease activity in TB infections. MMP is a zinc-
dependent protease, which plays a role in the process 
of degradation of the extracellular matrix and modulates 
the inflammatory response by facilitating and inhibiting 
different cytokines [6].
Two gelatinases, MMP-2 and MMP-9, 
have the ability to reduce original type IV collagen 
and denaturation of type I collagen (gelatin). Both 
circulation and resident inflammatory cells have the 
capacity to synthesize MMP-9. Experimental studies 
have provided evidence that MMP-9 levels were 
significantly higher in bronchoalveolar fluid patients 
with cavitary active TB and lung extracts of mice 
infected with M. tuberculous, compared to the control 
group [9], [10], [11].
In a study conducted by Hrabec et al., 2002 
[8], it was found that serum MMP-9 levels in patients 
with active pulmonary TB had significantly higher 
levels of the control group with mean MMP-9 levels in 
the group with pulmonary TB 1.23 ± 0.43 µU/µL, while 
the mean MMP-9 level in the control group was 0.37 
± 0.10 µU/µL and this result was in accordance with 
the function of MMP-9 which could induce enzymes 
produced by mononuclear phagocytes and stimulated 
neutrophils. In this study, no correlation was found 
between the duration of consumption of anti-TB drug 
and an increase in serum MMP-9 levels (p > 0.05) with 
an average use for TB medicines 9.14 ± 5.29 weeks, 
although this was not a primary goal in this study, but 
need to be reviewed, because this assessment only 
uses seven research subjects.
Conclusion
From the results of the comparison of serum 
MMP-9 values in ST with DSD, it was found that the 
serum MMP-9 values in ST gave higher results so that 
MMP-9 examination could be used as a barometer for 
the diagnosis of ST.
Further studies are needed to find out whether 
the increase in serum MMP-9 levels in TB spondylitis is 
also accompanied by an increase in the ratio of white blood 
cells and further studies are needed to determine whether 
an increase in serum MMP-9 levels can also be influenced 
by the duration of use of anti-tuberculous drugs.
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